Understand the source comparison
How to Use Peptides for Autoimmune: Research Protocol Comparison
Systemic Autoimmunity (Lupus, RA, MS) Thymalin Thymic regeneration and Treg expansion via thymulin secretion 5–10mg subcutaneous twice weekly 8–12 weeks for measurable Treg increase, 16–24 weeks for symptom reduction Best for multi-organ autoimmunity with docu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Systemic Autoimmunity (Lupus, RA, MS)
- Thymalin
- Thymic regeneration and Treg expansion via thymulin secretion
- 5–10mg subcutaneous twice weekly
- 8–12 weeks for measurable Treg increase, 16–24 weeks for symptom reduction
- Best for multi-organ autoimmunity with documented Treg depletion. Requires long-term commitment
- Gut-Origin Autoimmunity (Crohn's, Ulcerative Colitis, Hashimoto's with leaky gut)
- KPV 5MG
- NF-κB inhibition in intestinal epithelium, reduces IL-6 and TNF-α
- 2.5–5mg oral or subcutaneous daily
- 4–8 weeks for mucosal barrier repair, 12 weeks for autoantibody reduction
- Most effective when intestinal permeability is confirmed via lactulose-mannitol testing
- Tissue Repair and Barrier Restoration
- BPC-157
- VEGF-mediated angiogenesis and collagen synthesis in damaged tissues
- 250–500mcg subcutaneous daily
- 6–12 weeks for tissue regeneration, variable for immune stabilization
- Adjunct to immune-modulating peptides. Not a standalone autoimmune protocol
- Neurological Autoimmunity (MS, Guillain-Barré sequelae)
- Cerebrolysin + Thymalin
- Neurotrophic support and immune regulation
- Cerebrolysin 5–10mL IV 5 days/week for 4 weeks, Thymalin 5mg twice weekly ongoing
- 12–16 weeks for neurological recovery markers, 24+ weeks for immune stabilization
- Requires clinical oversight. Neurotrophic peptides interact with immune-modulating compounds